Ois Podcast
Alimera CEO Myers Shares Lessons From Iluvien FDA Approval
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:17:49
- Mais informações
Informações:
Sinopse
The FDA turned away Alimera Sciences’ bid to market Iluvien as a treatment for diabetic macular edema three times before finally giving the green light. President & CEO Dan Myers shares what kept his confidence up during this lengthy review and how Alimera Sciences is positioning Iluvien in the DME market.
